Panion & Bf Biotech Inc. (TPE:1760)

Panion & Bf Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,040	2,030	1,882	2,399	1,901	1,569
Revenue Growth (YoY)	0.20%	7.85%	-21.54%	26.16%	21.20%	-0.34%
Cost of Revenue	943.58	959.37	907.48	1,080	989.07	754.61
Gross Profit	1,096	1,070	974.4	1,319	912.14	814.03
Selling, General & Admin	607.48	618.22	601.58	656.06	587	560.16
Research & Development	200.13	236.88	217.04	248.5	157.71	127.02
Other Operating Expenses	0	9.84	-	-	-	18.91
Operating Expenses	806.62	864.61	817.57	904.63	746.8	709.53
Operating Income	289.6	205.67	156.83	413.96	165.34	104.5
Interest Expense	-14.69	-15.02	-11.36	-7.59	-14.68	-4.47
Interest & Investment Income	5.23	10.46	11.19	4.77	7.02	6.27
Earnings From Equity Investments	0.43	-8.44	-14.02	-8.18	-12.17	-13.13
Currency Exchange Gain (Loss)	-8.2	11.95	-2.97	-0.32	-3.07	-16.9
Other Non Operating Income (Expenses)	3.1	10.77	21.33	17.55	33.84	7.17
EBT Excluding Unusual Items	275.47	215.39	161.01	420.2	176.28	83.45
Gain (Loss) on Sale of Investments	-0.98	1.46	7.5	-93.68	6.72	5.79
Gain (Loss) on Sale of Assets	-0.13	-0.1	-0.38	6.28	-0.44	-
Other Unusual Items	0.69	0.69	0.58	0.61	0.08	0.17
Pretax Income	275.05	217.44	168.71	333.41	182.65	89.41
Income Tax Expense	100.68	92.91	91.49	151.06	78.25	61.51
Earnings From Continuing Operations	174.37	124.52	77.22	182.35	104.4	27.9
Net Income	174.37	124.52	77.22	182.35	104.4	27.9
Net Income to Common	174.37	124.52	77.22	182.35	104.4	27.9
Net Income Growth	43.71%	61.26%	-57.65%	74.66%	274.19%	-82.71%
Shares Outstanding (Basic)	86	86	86	86	79	77
Shares Outstanding (Diluted)	86	86	86	86	79	77
Shares Change (YoY)	0.04%	0.01%	-0.04%	8.32%	3.18%	-0.06%
EPS (Basic)	2.03	1.45	0.90	2.13	1.32	0.36
EPS (Diluted)	2.03	1.45	0.90	2.12	1.32	0.36
EPS Growth	43.45%	61.11%	-57.55%	60.78%	266.26%	-82.86%
Free Cash Flow	169.23	165.49	-3.81	291.23	231.22	-115.72
Free Cash Flow Per Share	1.97	1.93	-0.04	3.39	2.92	-1.51
Dividend Per Share	1.800	1.800	1.500	2.000	1.500	0.700
Dividend Growth	20.00%	20.00%	-25.00%	33.33%	114.29%	-61.11%
Gross Margin	53.74%	52.73%	51.78%	54.97%	47.98%	51.89%
Operating Margin	14.20%	10.13%	8.33%	17.26%	8.70%	6.66%
Profit Margin	8.55%	6.13%	4.10%	7.60%	5.49%	1.78%
Free Cash Flow Margin	8.30%	8.15%	-0.20%	12.14%	12.16%	-7.38%
EBITDA	406.45	341.73	298.19	546.26	275.7	160.18
EBITDA Margin	19.93%	16.84%	15.85%	22.77%	14.50%	10.21%
D&A For EBITDA	116.85	136.06	141.36	132.29	110.36	55.68
EBIT	289.6	205.67	156.83	413.96	165.34	104.5
EBIT Margin	14.20%	10.13%	8.33%	17.26%	8.70%	6.66%
Effective Tax Rate	36.61%	42.73%	54.23%	45.31%	42.84%	68.79%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.